Hasil Pencarian  ::  Simpan CSV :: Kembali

"[ABSTRAKBCG telah digunakan sebagai upaya mencegah infeksi tuberculosis selama lebih dari 90 tahun. Penelitian ini dilakukan untuk melihat efek pemberian vaksin BCG melalui rute subkutan di area dorsal leher dan paha pada mencit galur Swiss sekaligus menguji potensi pasak bumi (PB) sebagai imunomodulator setelah imunisasi BCG dengan mengukur IgG1 dan IgG3 menggunakan metode ELISA. Penelitian ini merupakan bagian dari proyek penelitian mengkaji potensi ekstrak akar pasak bumi pada beberapa infeksi pathogen intraseluler. Hasilnya pemberian vaksin BCG melalui rute subkutan di area leher lebih efektif (p<0.05) meningkatkan kadar IgG1 (OD kelompok air 2.162±0.231; kelompok PB 2.138±0.214) dan IgG3 (OD kelompok air 2.564±0.286; kelompok PB 2.521±0.228) pada mencit dibandingkan kadar IgG1 (OD kelompok air 0.817±0.101; kelompok PB 0.796±0.207) dan IgG3 (OD kelompok air 1.290±0.104; kelompok PB 1.260±0.093) pada vaksinasi BCG secara subkutan di area paha. Sementara itu potensi ekstrak akar pasak bumi dalam memodulasi produksi IgG1 dan IgG3 paska injeksi BCG belum terlihat pada percobaan ini.

---

ABSTRACTBCG has been used as an effort to prevent tuberculosis for more than 90 years. The aim of this research were to investigate the effect of BCG vaccine administration trough subcutaneous route over the neck and on the thigh of mice of Swiss strain as well as to evaluate the potency of pasak bumi (PB) as immunomodulator in IgG1 and IgG3 productions after BCG vaccination. This research is part of a bigger project to analyse the potency of pasak bumi as an immunomodulator over intracellular pathogen infections. The result shows that BCG vaccination through subcutaneous over the neck was more effective (p<0.05) in generating IgG1 (OD group with water 2.162±0.231; group with PB 2.138±0.214) and IgG3 (OD group with water 2.564±0.286; group with PB 2.521±0.228) on mice compare to IgG1 level (OD group with water 0.817±0.101; group with PB 0.796±0.207) and IgG3 (OD group with water 1.290±0.104; group with PB 1.260±0.093) on subcutaneous vaccination on thigh area. The potency of pasak bumi root extract in modulating the production of IgG1 and IgG3 has not seen in this experiment.;BCG has been used as an effort to prevent tuberculosis for more than 90 years. The aim of this research were to investigate the effect of BCG vaccine administration trough subcutaneous route over the neck and on the thigh of mice of Swiss strain as well as to evaluate the potency of pasak bumi (PB) as immunomodulator in IgG1 and IgG3 productions after BCG vaccination. This research is part of a bigger project to analyse the potency of pasak bumi as an immunomodulator over intracellular pathogen infections. The result shows that BCG vaccination through subcutaneous over the neck was more effective (p<0.05) in generating IgG1 (OD group with water 2.162±0.231; group with PB 2.138±0.214) and IgG3 (OD group with water 2.564±0.286; group with PB 2.521±0.228) on mice compare to IgG1 level (OD group with water 0.817±0.101; group with PB 0.796±0.207) and IgG3 (OD group with water 1.290±0.104; group with PB 1.260±0.093) on subcutaneous vaccination on thigh area. The potency of pasak bumi root extract in modulating the production of IgG1 and IgG3 has not seen in this experiment., BCG has been used as an effort to prevent tuberculosis for more than 90 years. The aim of this research were to investigate the effect of BCG vaccine administration trough subcutaneous route over the neck and on the thigh of mice of Swiss strain as well as to evaluate the potency of pasak bumi (PB) as immunomodulator in IgG1 and IgG3 productions after BCG vaccination. This research is part of a bigger project to analyse the potency of pasak bumi as an immunomodulator over intracellular pathogen infections. The result shows that BCG vaccination through subcutaneous over the neck was more effective (p<0.05) in generating IgG1 (OD group with water 2.162±0.231; group with PB 2.138±0.214) and IgG3 (OD group with water 2.564±0.286; group with PB 2.521±0.228) on mice compare to IgG1 level (OD group with water 0.817±0.101; group with PB 0.796±0.207) and IgG3 (OD group with water 1.290±0.104; group with PB 1.260±0.093) on subcutaneous vaccination on thigh area. The potency of pasak bumi root extract in modulating the production of IgG1 and IgG3 has not seen in this experiment.]"

"[Malaria masih menjadi beban kesehatan bagi Indonesia, terlebih lagi dengan perkembangan resistensi parasit terhadap pengobatan saat ini. Untuk itu, diperlukan penemuan terapi baru dengan segera. Pasak Bumi (Eurycoma longifolia) adalah tanaman asli Kalimantan yang terbukti secara in vitro dan in vivo memiliki aktivitas antiplasmodium. Penelitian ini ingin menguji efektivitas kombinasi ekstrak akar Pasak Bumi dosis 10 mg/kgBB (PB10) dan 20 mg/kgBB (PB20) dengan Artemisinin-based Combination Therapy (ACT) dosis 1,7 mg/kgBB pada mencit Swiss yang terinfeksi Plasmodium berghei. Pemberian obat dilakukan secara subkutan untuk meningkatkan bioavailabilitasnya, sehingga didapatkan hasil yang maksimal. Dengan menggunakan metode 4-day suppressive test, didapatkan pertumbuhan densitas parasitemia dan persentase inhibisi pertumbuhan secara berturut-turut: kontrol positif 22,08% dan 50,92%, PB10+ACT 5,22% dan 88,4%, PB20+ACT 3,5% dan 92,22%. Pemberian kombinasi meningkatkan efektivitas secara signifikan terhadap PB tunggal, tetapi tidak signifikan terhadap ACT tunggal. Meskipun demikian, peningkatan tersebut mengindikasikan adanya efek sinergis dari kedua zat dan membutuhkan penelitian lebih lanjut. Dari semua perlakuan, PB20+ACT memiliki efek antimalaria yang paling baik.;Malaria is still considered as a burden disease for Indonesia, especially with the fast developing resistance of parasite against current medication. Hence, the invention of novel therapy is needed immediately. Pasak Bumi (Eurycoma longifolia), a native plant in Kalimantan, has been proven to have in vivo and in vitro antiplasmodial activity. This study aims to test the effect of combination of E.longifolia and Artemisinin-based Combination Therapy (ACT) both given subcutaneously on parasitemia in mice infected with Plasmodium berghei. The doses of the extract tested in this experimental study were 10 (PB10) and 20 mg/kg BW (PB20). Using the 4-day suppressive test, the growth of parasite and growth inhibition percetage of each groups are as following: positive control 22,08% and 50,92%, PB10+ACT 5,22% and 88,4%, PB20+ACT 3,5% and 92,22%. The combination therapy showed significant increase in effectiveness compared to PB monotherapy but insignificant increase compared to ACT monotherapy. Despite the insignificance, this indicates synergistic effect of the two substances that needs further investigation. Among all groups, PB20+ACT showed the best antimalarial activity, Malaria is still considered as a burden disease for Indonesia, especially with the fast developing resistance of parasite against current medication. Hence, the invention of novel therapy is needed immediately. Pasak Bumi (Eurycoma longifolia), a native plant in Kalimantan, has been proven to have in vivo and in vitro antiplasmodial activity. This study aims to test the effect of combination of E.longifolia and Artemisinin-based Combination Therapy (ACT) both given subcutaneously on parasitemia in mice infected with Plasmodium berghei. The doses of the extract tested in this experimental study were 10 (PB10) and 20 mg/kg BW (PB20). Using the 4-day suppressive test, the growth of parasite and growth inhibition percetage of each groups are as following: positive control 22,08% and 50,92%, PB10+ACT 5,22% and 88,4%, PB20+ACT 3,5% and 92,22%. The combination therapy showed significant increase in effectiveness compared to PB monotherapy but insignificant increase compared to ACT monotherapy. Despite the insignificance, this indicates synergistic effect of the two substances that needs further investigation. Among all groups, PB20+ACT showed the best antimalarial activity]"